NUCLEOSID-DERIVATE UND DEREN VERWENDUNG ALS ARZNEIMITTEL
Nucleosides of formula (I), their anomers, N7 and N9 regioisomeric tautomers and salts, and nucleic acids based on them are new, where Ba= a gp. of formula (A), (B), (C), (D), (E) or (F). R1-3= H, halogen, alkyl, OH, SH, NO2, NH2, thioalkyl, alkoxy, aralkyl, aralkoxy, aminoalkyl, (di)alkylaminoalkyl...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GUMBIOWSKI, RAINER ZILCH, HARALD KOENIG, BERNHARD ROSEMEYER, HELMUT SEELA, FRANK ROELING, ANGELIKA KOCH, EDITH BOURGEOIS, WERNER MERTENS, ALFRED |
| description | Nucleosides of formula (I), their anomers, N7 and N9 regioisomeric tautomers and salts, and nucleic acids based on them are new, where Ba= a gp. of formula (A), (B), (C), (D), (E) or (F). R1-3= H, halogen, alkyl, OH, SH, NO2, NH2, thioalkyl, alkoxy, aralkyl, aralkoxy, aminoalkyl, (di)alkylaminoalkyl, NHR4, N(R4)2 or N=CHR4. R4= alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, alkoxyalkyl, haloalkyl, hydroxyalkyl, aminoalkyl, mono- or di- alkylaminoalkyl or aralkyl or heteroarylalkyl both opt. substd. with alkyl, alkoxy, halogen or OH; and when R4 occurs in NHR4 or N=CHR4 it may also be NH2, mono- or di-alkylamino or alkoxy. Y=H, alkylcarbonyl or mono-, di- or tri- phosphate. R5-R8= H or 1-2 of R5-R8 are OH, halogen, CN, N3, NHR4, N(R4)2, or R5 and R7 together form an additional bond between C2' and C3'. Provided that: (a) when Ba=(B) R6 is not H, N3 or NH2. (b) when Ba=(D) and R2=H then R1 is not Cl or NH2 and R6 is not H or Cl. (c) when Ba=(E) then R5 and R7 do not form a bond. Prepn. of (I), their use in DNA sequencing and antiviral compsns. contg. new and known (I) are also claime |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE130306TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE130306TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE130306TT13</originalsourceid><addsrcrecordid>eNrjZLDwC3X2cfUP9nTRdXEN8gxzDHFVCPVzUQByXP0UwlyDwl39XEL93BUcfYIVHIOi_Fw9fT1DQlx9eBhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJPNA8Q2MDYwOzkBBDY2LUAACLySk0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NUCLEOSID-DERIVATE UND DEREN VERWENDUNG ALS ARZNEIMITTEL</title><source>esp@cenet</source><creator>GUMBIOWSKI, RAINER ; ZILCH, HARALD ; KOENIG, BERNHARD ; ROSEMEYER, HELMUT ; SEELA, FRANK ; ROELING, ANGELIKA ; KOCH, EDITH ; BOURGEOIS, WERNER ; MERTENS, ALFRED</creator><creatorcontrib>GUMBIOWSKI, RAINER ; ZILCH, HARALD ; KOENIG, BERNHARD ; ROSEMEYER, HELMUT ; SEELA, FRANK ; ROELING, ANGELIKA ; KOCH, EDITH ; BOURGEOIS, WERNER ; MERTENS, ALFRED</creatorcontrib><description>Nucleosides of formula (I), their anomers, N7 and N9 regioisomeric tautomers and salts, and nucleic acids based on them are new, where Ba= a gp. of formula (A), (B), (C), (D), (E) or (F). R1-3= H, halogen, alkyl, OH, SH, NO2, NH2, thioalkyl, alkoxy, aralkyl, aralkoxy, aminoalkyl, (di)alkylaminoalkyl, NHR4, N(R4)2 or N=CHR4. R4= alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, alkoxyalkyl, haloalkyl, hydroxyalkyl, aminoalkyl, mono- or di- alkylaminoalkyl or aralkyl or heteroarylalkyl both opt. substd. with alkyl, alkoxy, halogen or OH; and when R4 occurs in NHR4 or N=CHR4 it may also be NH2, mono- or di-alkylamino or alkoxy. Y=H, alkylcarbonyl or mono-, di- or tri- phosphate. R5-R8= H or 1-2 of R5-R8 are OH, halogen, CN, N3, NHR4, N(R4)2, or R5 and R7 together form an additional bond between C2' and C3'. Provided that: (a) when Ba=(B) R6 is not H, N3 or NH2. (b) when Ba=(D) and R2=H then R1 is not Cl or NH2 and R6 is not H or Cl. (c) when Ba=(E) then R5 and R7 do not form a bond. Prepn. of (I), their use in DNA sequencing and antiviral compsns. contg. new and known (I) are also claime</description><edition>6</edition><language>ger</language><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS OR TEST PAPERS THEREFOR ; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ; DERIVATIVES THEREOF ; ENZYMOLOGY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MUTATION OR GENETIC ENGINEERING ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROCESSES OF PREPARING SUCH COMPOSITIONS ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPIRITS ; SUGARS ; VINEGAR ; WINE</subject><creationdate>1995</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19951215&DB=EPODOC&CC=AT&NR=E130306T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19951215&DB=EPODOC&CC=AT&NR=E130306T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GUMBIOWSKI, RAINER</creatorcontrib><creatorcontrib>ZILCH, HARALD</creatorcontrib><creatorcontrib>KOENIG, BERNHARD</creatorcontrib><creatorcontrib>ROSEMEYER, HELMUT</creatorcontrib><creatorcontrib>SEELA, FRANK</creatorcontrib><creatorcontrib>ROELING, ANGELIKA</creatorcontrib><creatorcontrib>KOCH, EDITH</creatorcontrib><creatorcontrib>BOURGEOIS, WERNER</creatorcontrib><creatorcontrib>MERTENS, ALFRED</creatorcontrib><title>NUCLEOSID-DERIVATE UND DEREN VERWENDUNG ALS ARZNEIMITTEL</title><description>Nucleosides of formula (I), their anomers, N7 and N9 regioisomeric tautomers and salts, and nucleic acids based on them are new, where Ba= a gp. of formula (A), (B), (C), (D), (E) or (F). R1-3= H, halogen, alkyl, OH, SH, NO2, NH2, thioalkyl, alkoxy, aralkyl, aralkoxy, aminoalkyl, (di)alkylaminoalkyl, NHR4, N(R4)2 or N=CHR4. R4= alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, alkoxyalkyl, haloalkyl, hydroxyalkyl, aminoalkyl, mono- or di- alkylaminoalkyl or aralkyl or heteroarylalkyl both opt. substd. with alkyl, alkoxy, halogen or OH; and when R4 occurs in NHR4 or N=CHR4 it may also be NH2, mono- or di-alkylamino or alkoxy. Y=H, alkylcarbonyl or mono-, di- or tri- phosphate. R5-R8= H or 1-2 of R5-R8 are OH, halogen, CN, N3, NHR4, N(R4)2, or R5 and R7 together form an additional bond between C2' and C3'. Provided that: (a) when Ba=(B) R6 is not H, N3 or NH2. (b) when Ba=(D) and R2=H then R1 is not Cl or NH2 and R6 is not H or Cl. (c) when Ba=(E) then R5 and R7 do not form a bond. Prepn. of (I), their use in DNA sequencing and antiviral compsns. contg. new and known (I) are also claime</description><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS OR TEST PAPERS THEREFOR</subject><subject>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</subject><subject>DERIVATIVES THEREOF</subject><subject>ENZYMOLOGY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROCESSES OF PREPARING SUCH COMPOSITIONS</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPIRITS</subject><subject>SUGARS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1995</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDwC3X2cfUP9nTRdXEN8gxzDHFVCPVzUQByXP0UwlyDwl39XEL93BUcfYIVHIOi_Fw9fT1DQlx9eBhY0xJzilN5oTQ3g6Kba4izh25qQX58anFBYnJqXmpJPNA8Q2MDYwOzkBBDY2LUAACLySk0</recordid><startdate>19951215</startdate><enddate>19951215</enddate><creator>GUMBIOWSKI, RAINER</creator><creator>ZILCH, HARALD</creator><creator>KOENIG, BERNHARD</creator><creator>ROSEMEYER, HELMUT</creator><creator>SEELA, FRANK</creator><creator>ROELING, ANGELIKA</creator><creator>KOCH, EDITH</creator><creator>BOURGEOIS, WERNER</creator><creator>MERTENS, ALFRED</creator><scope>EVB</scope></search><sort><creationdate>19951215</creationdate><title>NUCLEOSID-DERIVATE UND DEREN VERWENDUNG ALS ARZNEIMITTEL</title><author>GUMBIOWSKI, RAINER ; ZILCH, HARALD ; KOENIG, BERNHARD ; ROSEMEYER, HELMUT ; SEELA, FRANK ; ROELING, ANGELIKA ; KOCH, EDITH ; BOURGEOIS, WERNER ; MERTENS, ALFRED</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE130306TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>1995</creationdate><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS OR TEST PAPERS THEREFOR</topic><topic>CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES</topic><topic>DERIVATIVES THEREOF</topic><topic>ENZYMOLOGY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROCESSES OF PREPARING SUCH COMPOSITIONS</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPIRITS</topic><topic>SUGARS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>GUMBIOWSKI, RAINER</creatorcontrib><creatorcontrib>ZILCH, HARALD</creatorcontrib><creatorcontrib>KOENIG, BERNHARD</creatorcontrib><creatorcontrib>ROSEMEYER, HELMUT</creatorcontrib><creatorcontrib>SEELA, FRANK</creatorcontrib><creatorcontrib>ROELING, ANGELIKA</creatorcontrib><creatorcontrib>KOCH, EDITH</creatorcontrib><creatorcontrib>BOURGEOIS, WERNER</creatorcontrib><creatorcontrib>MERTENS, ALFRED</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GUMBIOWSKI, RAINER</au><au>ZILCH, HARALD</au><au>KOENIG, BERNHARD</au><au>ROSEMEYER, HELMUT</au><au>SEELA, FRANK</au><au>ROELING, ANGELIKA</au><au>KOCH, EDITH</au><au>BOURGEOIS, WERNER</au><au>MERTENS, ALFRED</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NUCLEOSID-DERIVATE UND DEREN VERWENDUNG ALS ARZNEIMITTEL</title><date>1995-12-15</date><risdate>1995</risdate><abstract>Nucleosides of formula (I), their anomers, N7 and N9 regioisomeric tautomers and salts, and nucleic acids based on them are new, where Ba= a gp. of formula (A), (B), (C), (D), (E) or (F). R1-3= H, halogen, alkyl, OH, SH, NO2, NH2, thioalkyl, alkoxy, aralkyl, aralkoxy, aminoalkyl, (di)alkylaminoalkyl, NHR4, N(R4)2 or N=CHR4. R4= alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, alkoxyalkyl, haloalkyl, hydroxyalkyl, aminoalkyl, mono- or di- alkylaminoalkyl or aralkyl or heteroarylalkyl both opt. substd. with alkyl, alkoxy, halogen or OH; and when R4 occurs in NHR4 or N=CHR4 it may also be NH2, mono- or di-alkylamino or alkoxy. Y=H, alkylcarbonyl or mono-, di- or tri- phosphate. R5-R8= H or 1-2 of R5-R8 are OH, halogen, CN, N3, NHR4, N(R4)2, or R5 and R7 together form an additional bond between C2' and C3'. Provided that: (a) when Ba=(B) R6 is not H, N3 or NH2. (b) when Ba=(D) and R2=H then R1 is not Cl or NH2 and R6 is not H or Cl. (c) when Ba=(E) then R5 and R7 do not form a bond. Prepn. of (I), their use in DNA sequencing and antiviral compsns. contg. new and known (I) are also claime</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | ger |
| recordid | cdi_epo_espacenet_ATE130306TT1 |
| source | esp@cenet |
| subjects | ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES DERIVATIVES THEREOF ENZYMOLOGY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS SUGARS VINEGAR WINE |
| title | NUCLEOSID-DERIVATE UND DEREN VERWENDUNG ALS ARZNEIMITTEL |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T05%3A47%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GUMBIOWSKI,%20RAINER&rft.date=1995-12-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE130306TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |